Skip to search formSkip to main contentSkip to account menu

Insulin, Glulisine, Human

Known as: insulin, Lys(B3)-Glu(B29)-, glulisine insulin, INSULIN GLULISINE 
A drug used to control the amount of sugar in the blood of patients with diabetes mellitus. It is a form of the hormone insulin that is made in the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Objective: This study evaluated patient satisfaction with SoloSTAR® (sanofi-aventis), a prefilled insulin pen device for… 
2011
2011
Background: The objective of this study was to characterize how successfully patients with diabetes are able to distinguish… 
2009
2009
Aim:  Little is known about the dose–response relationships of rapid‐acting insulin analogues in subjects with diabetes. This… 
2009
2009
Aim: The rapid‐acting insulin analogue insulin glulisine (glulisine) was compared with insulin lispro (lispro) for efficacy and… 
Review
2007
Review
2007
SoloStar® (sanofi-aventis) is a new, disposable insulin pen for the administration of insulin glargine (Lantus®, sanofi-aventis… 
2006
2006
Receptor binding and signaling and the mitogenic potential of insulin glulisine (glulisine), regular human insulin (RHI), and Asp… 
2005
2005
Aims/hypothesisNew insulin analogues have been created by amino-acid exchange to provide an improved pharmacokinetic profile… 
Review
2003
Review
2003
Aventis Pharma (formerly Hoechst Marion Roussel) is developing insulin glulisine, a fast-acting insulin analog, for the potential…